_version_ 1784617829893406720
author Picard, Matthieu
Drolet, Jean-Philippe
Masse, Marie-Soleil
Filion, Charles A.
ALMuhizi, Faisal
Fein, Michael
Copaescu, Ana
Isabwe, Ghislaine Annie C.
Blaquière, Martin
Primeau, Marie-Noël
author_facet Picard, Matthieu
Drolet, Jean-Philippe
Masse, Marie-Soleil
Filion, Charles A.
ALMuhizi, Faisal
Fein, Michael
Copaescu, Ana
Isabwe, Ghislaine Annie C.
Blaquière, Martin
Primeau, Marie-Noël
author_sort Picard, Matthieu
collection PubMed
description
format Online
Article
Text
id pubmed-8685412
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-86854122021-12-20 Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series Picard, Matthieu Drolet, Jean-Philippe Masse, Marie-Soleil Filion, Charles A. ALMuhizi, Faisal Fein, Michael Copaescu, Ana Isabwe, Ghislaine Annie C. Blaquière, Martin Primeau, Marie-Noël J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2022-02 2021-12-20 /pmc/articles/PMC8685412/ /pubmed/34949564 http://dx.doi.org/10.1016/j.jaip.2021.11.021 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Communications
Picard, Matthieu
Drolet, Jean-Philippe
Masse, Marie-Soleil
Filion, Charles A.
ALMuhizi, Faisal
Fein, Michael
Copaescu, Ana
Isabwe, Ghislaine Annie C.
Blaquière, Martin
Primeau, Marie-Noël
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
title Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
title_full Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
title_fullStr Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
title_full_unstemmed Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
title_short Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
title_sort safety of covid-19 vaccination in patients with polyethylene glycol allergy: a case series
topic Clinical Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685412/
https://www.ncbi.nlm.nih.gov/pubmed/34949564
http://dx.doi.org/10.1016/j.jaip.2021.11.021
work_keys_str_mv AT picardmatthieu safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries
AT droletjeanphilippe safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries
AT massemariesoleil safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries
AT filioncharlesa safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries
AT almuhizifaisal safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries
AT feinmichael safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries
AT copaescuana safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries
AT isabweghislaineanniec safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries
AT blaquieremartin safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries
AT primeaumarienoel safetyofcovid19vaccinationinpatientswithpolyethyleneglycolallergyacaseseries